ADC-7405

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameADC-7405
Drug Alias NameADC-7405
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProstaglandin D2 receptor 2 antagonistsProstaglandin-H2 D-isomerase inhibitors
TargetsProstaglandin-H2 D-isomeraseProstaglandin D2 receptor 2
Therapy Area/IndicationsAsthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPulmagen Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPulmagen Therapeutics
Active IndicationsN/A
Inactive IndicationsAsthma

Other Information

ATC CodeN/A
Related LinksN/A